Korro Bio Inc.
KRRO | NASDAQ
$9.98
-$0.04 (-0.40%)
At close: Sep 21, 2026, 4:00 PM ET
$10.17
+$0.19 (+1.90%)
Pre-market:
Sep 22, 2026, 8:11 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.39M | 2.27M | n/a | n/a | n/a | 36.98M |
Cost of Revenue | 4.28M | n/a | n/a | n/a | n/a | 1.58M |
Gross Profit | 2.11M | 2.27M | n/a | n/a | n/a | 35.4M |
Operating Income | -87.34M | -91.91M | -84.53M | -59M | -35.49M | -27.55M |
Interest Income | n/a | n/a | n/a | 947K | n/a | 994K |
Pretax Income | -116.62M | -83.44M | -81.15M | -58.02M | -21.96M | -26.48M |
Net Income | -117.26M | -83.58M | -81.17M | -58.03M | -21.96M | -26.51M |
Selling & General & Admin | 28.16M | 30.55M | 36.54M | 16.8M | 11.69M | 26.3M |
Research & Development | 65.58M | 63.64M | 57.25M | 42.2M | 23.81M | 36.66M |
Other Expenses | -4.28M | n/a | -9.25M | n/a | n/a | n/a |
Operating Expenses | 89.45M | 94.18M | 84.53M | 59M | 35.49M | 62.95M |
Interest Expense | n/a | n/a | n/a | 118K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 12.51M | n/a | n/a | n/a |
Cost & Expenses | 93.73M | 94.18M | 84.53M | 59M | 35.49M | 64.53M |
Income Tax Expense | 637K | 141K | 27K | 10K | 2K | 35K |
Shares Outstanding (Basic) | 9.4M | 8.92M | 1.53M | 255K | 4.45M | 645.06K |
Shares Outstanding (Diluted) | 9.4M | 8.92M | 1.53M | 255.17K | 4.45M | 645.06K |
EPS (Basic) | -12.48 | -9.37 | -53.09 | -227.58 | -4.94 | -41.10 |
EPS (Diluted) | -12.48 | -9.37 | -53.08 | -227.42 | -4.94 | -41.10 |
EBITDA | -83.06M | -88.35M | -80.9M | -56.49M | -33.9M | -24.9M |
EBIT | -87.34M | -91.91M | -84.53M | -59M | -35.49M | -26.48M |
Depreciation & Amortization | 4.28M | 3.57M | 3.63M | 2.51M | 1.6M | 1.58M |
Add to Watchlist
Select watchlists to add or remove KRRO